BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16158262)

  • 21. An approach to the skeleton of the securinega alkaloids. The total synthesis of (+/-)-securinine.
    Liras S; Davoren JE; Bordner J
    Org Lett; 2001 Mar; 3(5):703-6. PubMed ID: 11259041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PARTIAL SYNTHESIS OF SECURININE.
    SAITO S; SHIGEMATSU N; YOSHIKAWA H; HORII Z; TAMURA Y
    Chem Pharm Bull (Tokyo); 1963 Sep; 11():1219-20. PubMed ID: 14068754
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on securinine. I. Isolation and correlation of Securinega alkaloids].
    HORII ZI; TANAKA T; TAMURA Y; SAITO S; MATSUMURA C; SUGIMOTO N
    Yakugaku Zasshi; 1963 Jun; 83():602-5. PubMed ID: 13961782
    [No Abstract]   [Full Text] [Related]  

  • 24. Enantioselective approach to Securinega alkaloids. Total synthesis of securinine and (-)-norsecurinine.
    González-Gálvez D; García-García E; Alibés R; Bayón P; de March P; Figueredo M; Font J
    J Org Chem; 2009 Aug; 74(16):6199-211. PubMed ID: 19627163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [POLAROMETRIC DETERMINATION OF SECURININE].
    ROSTOTSKII BK; KRIVUT BA; LASSKAIA OE
    Med Prom SSSR; 1964 Mar; 18():51-3. PubMed ID: 14185063
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological comparison between virosecurinine and securinine].
    Pu H; Zhao J; Pong B; Xu S
    Zhong Yao Cai; 2001 Apr; 24(4):278-80. PubMed ID: 12587161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some toxicologic properties of the alkaloids galanthamine and securinine.
    FRIESS SL; DURANT RC; WHITCOMB ER; REBER LJ; THOMMESEN WC
    Toxicol Appl Pharmacol; 1961 May; 3():347-57. PubMed ID: 13702084
    [No Abstract]   [Full Text] [Related]  

  • 28. Kinetics and mechanism of the alkaline hydrolysis of securinine.
    Lajis NH; Noor HM; Khan MN
    J Pharm Sci; 1995 Jan; 84(1):126-30. PubMed ID: 7714735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ON THE ABSOLUTE CONFIGURATION OF SECURININE.
    HORII Z; IKEDA M; YAMAWAKI Y; TAMURA Y; SAITO S; KODERA K
    Chem Pharm Bull (Tokyo); 1963 Jun; 11():817-8. PubMed ID: 14068723
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect and mechanism of securinine on synaptic transmission in the dentate gyrus of anesthetized rats].
    Xu L; Zhang JT
    Yao Xue Xue Bao; 2001 Aug; 36(8):565-8. PubMed ID: 12579930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular effects of lateral intracerebroventricular injection of L-securinine].
    Zhao XY; Jiang ZY; Peng JZ
    Sheng Li Xue Bao; 2000 Dec; 52(6):473-8. PubMed ID: 11941410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacologic analysis of the physiologic mechanisms of the hemodynamics of orthostatic tolerance].
    Osadchii LI
    Kosm Biol Aviakosm Med; 1980; 14(2):45-9. PubMed ID: 6104745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular calcium involved in the long-term potentiation induced by securinine in dentate gyrus of anesthetized rats.
    Lin X; Guolin W; Jun-tian Z
    Planta Med; 2002 Aug; 68(8):752-3. PubMed ID: 12221604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The adverse effects of the preparations of the active principles of Chinese herbal drugs].
    Zhang SC; Li SZ; Gao XC; Qian LH; Yang MZ; Yuan HN; Tan DJ
    Zhongguo Zhong Yao Za Zhi; 1993 Jul; 18(7):387-91. PubMed ID: 8267848
    [No Abstract]   [Full Text] [Related]  

  • 35. [DETERMINATION OF SECURININE AND ITS STEREOISOMERS IN PLANTS OF THE SECURINEGA SPECIES, AND ISOLATION OF VIROALLOSECURININE AND VIROSINE].
    SAITO S; TANAKA T; IWAMOTO T; MATSUMURA C; SUGIMOTO N; HORII Z; MAKITA M; IKEDA M; TAMURA Y
    Yakugaku Zasshi; 1964 Nov; 84():1126-33. PubMed ID: 14265139
    [No Abstract]   [Full Text] [Related]  

  • 36. [STUDIES ON THE EXTRACTION AND ISOLATION OF SECURININE FROM SECURINEGA SUFFRUTICOSA (PALL.) REHD. BY ADSORPTION WITH ACTIVE CARBON].
    LI LN; CHEN WM; FANG QC
    Yao Xue Xue Bao; 1962 Jun; 9():352-8. PubMed ID: 14075905
    [No Abstract]   [Full Text] [Related]  

  • 37. Securinega suffruticosa.
    Raj D; Luczkiewicz M
    Fitoterapia; 2008 Sep; 79(6):419-27. PubMed ID: 18534774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viability of a [2 + 2 + 1] Hetero-Pauson-Khand Cycloaddition Strategy toward Securinega Alkaloids: Synthesis of the BCD-Ring Core of Securinine and Related Alkaloids.
    Chirkin E; Michel S; Porée FH
    J Org Chem; 2015 Jul; 80(13):6525-8. PubMed ID: 26098882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OPTICAL ROTATORY DISPERSION AND CIRCULAR DICHROISM OF SECURININE AND ALLOSECURININE.
    HORII ZI; IKEDA M; TAMURA Y; SAITO S; SUZUKI M; KODERA K
    Chem Pharm Bull (Tokyo); 1964 Sep; 12():1118-21. PubMed ID: 14245278
    [No Abstract]   [Full Text] [Related]  

  • 40. The Securinega alkaloids.
    Chirkin E; Atkatlian W; Porée FH
    Alkaloids Chem Biol; 2015; 74():1-120. PubMed ID: 25845059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.